// App-Quantinova.ai

2315 : The LGR5 monoclonal antibody BNC101 has anti-tumor and anti-cancer stem cell activity in pancreatic cancer

Researchers

Presenter

  • Farbod Shojaei

Principal Investigators

  • Colin Walsh

  • Kristen Smith

  • Camino Menendez

  • Pedro Lopez

  • John Norton

  • Jose Iglesias

  • Manuel Hidalgo

  • Christopher Reyes

  • Peter Chu

Medical Centers

  • CNIO, Madrid, Spain

Locations

  • Spain

Companies

  • Bionomics

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreatic cancer

  • Colorectal Cancer

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • Gemcitabine

  • Protein-bound paclitaxel

  • BNC101

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved